Showing results (781-790 of 13,585) with videos related to
Sort By:
Pageof 1,359
Atherosclerosis|September 22, 2018
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrelFabio Mangiacapra, Mariano Pellicano, Luigi Di Serafino, et al.Atherosclerosis|September 26, 2018
CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversiesAllison B Reiss, Nobuyuki Miyawaki, Jane Moon, et al.Atherosclerosis|April 9, 2019
Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-studyToralph Ruge, Axel C Carlsson, Erik Kjøller, et al.Atherosclerosis|December 1, 1985
The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferationJ Nilsson, M Sjölund, L Palmberg, et al.Atherosclerosis|January 1, 1986
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulationsA S Antonov, M A Nikolaeva, T S Klueva, et al.Atherosclerosis|June 8, 2018
Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE-/-:Ins2+/Akita mouse fed a western dietDaniel E Venegas-Pino, Andrew Lagrotteria, Pei-Wen Wang, et al.Atherosclerosis|June 12, 2018
Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort studyHokuto Arase, Shunsuke Yamada, Ryusuke Yotsueda, et al.Atherosclerosis|May 11, 2018
Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debateKaram M Kostner, Gert M Kostner, Anthony S WierzbickiAtherosclerosis|May 11, 2018
Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adultsBoris Schmitz, Pieter Nelis, Florian Rolfes, et al.Atherosclerosis|February 1, 1986
Pharmacological profile of tazasubrate, a new cholesterol-lowering agentE Schulze, J Obermaier, C A Seyfried, et al.Pageof 1,359